BioAtla, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.94 | $223.86 M | -2.51 | 58 | $0 |
 ADAG
|
Adagene Inc. | $2.23 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANTX
|
AN2 Therapeutics, Inc. | $1.05 | $60.55 M | -0.81 | 41 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.08 | $597.48 M | -6.84 | 51 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $5.15 | $320.64 M | -1.97 | 145 | $20.76 M |
 DSGN
|
Design Therapeutics, Inc. | $4.55 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.45 | $647.94 M | -2.83 | 126 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $7.79 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.05 | $243.38 M | -1.59 | 129 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 IKNA
|
Ikena Oncology, Inc. | $1.69 | $84.45 M | -1.11 | 18 | $9.16 M |
 IPSC
|
Century Therapeutics, Inc. | $1.48 | $244.54 M | -1.32 | 152 | $2.24 M |
 KYMR
|
Kymera Therapeutics, Inc. | $42.19 | $2.02 B | -13.13 | 181 | $78.59 M |
 NAUT
|
Nautilus Biotechnology, Inc. | $2.66 | $325.69 M | -4.81 | 164 | $0 |
 NRIX
|
Nurix Therapeutics, Inc. | $21.55 | $930.10 M | -5.89 | 284 | $76.99 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $11.32 | $734.41 M | -6.56 | 80 | $0 |
 PASG
|
Passage Bio, Inc. | $0.59 | $73.04 M | -0.77 | 58 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.49 | $85.40 M | -1.26 | 63 | $0 |
 RZLT
|
Rezolute, Inc. | $4.79 | $229.57 M | -5.02 | 51 | $0 |
 STTK
|
Shattuck Labs, Inc. | $1.13 | $333.81 M | -3.64 | 75 | $1.66 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |